We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stem Cells Replace Stroke-Damaged Tissue in Lab Rats

By LabMedica International staff writers
Posted on 23 Mar 2009
Successful stem cell treatment for strokes has taken a significant step forward as scientists reveal how they have replaced stroke-damaged brain tissue in rats.

The team of scientists project is funded by the Biotechnology and Biological Sciences Research Council (BBSRC; Swindon, UK) and led by Dr. More...
Mike Modo of the Institute of Psychiatry, King's College London (UK). The study, performed at the Institute of Psychiatry and University of Nottingham (UK), shows that by inserting tiny scaffolding with stem cells attached, it is possible to fill a hole left by stroke damage with brand new brain tissue within seven days. The study was published in the March 2009 issue of the journal Biomaterials.

Earlier studies where stem cells have been injected into the void left by stroke damage have had some success in improving outcomes in rats. The difficulty is that in the damaged area there is no structural support for the stem cells and so they are apt to migrate into the surrounding healthy tissues instead of filling up the hole left by the stroke. Dr. Modo noted, "We would expect to see a much better improvement in the outcome after a stroke if we can fully replace the lost brain tissue, and that is what we have been able to do with our technique.”

Using individual particles of a biodegradable polymer called poly(lactide-co-glycolide) (PLGA) that have been loaded with neural stem cells, the team of scientists have filled stroke cavities with stem cells on a ready-made support structure. Dr. Modo continued, "This works really well because the stem cell-loaded PLGA particles can be injected through a very fine needle and then adopt the precise shape of the cavity. In this process the cells fill the cavity and can make connections with other cells, which helps to establish the tissue. Over a few days we can see cells migrating along the scaffold particles and forming a primitive brain tissue that interacts with the host brain. Gradually, the particles biodegrade, leaving more gaps and conduits for tissue, fibers, and blood vessels to move into.”

The research utilizes a magnetic resonance imaging (MRI) scanner to target precisely the correct place to inject the scaffold-cell structure. MRI is also used to monitor the development of the new brain tissue over time. The next stage of the study will be to include a factor called vascular endothelial growth factor (VEGF) with the particles. VEGF will encourage blood vessels to enter the new tissue.

Related Links:

King's College London
University of Nottingham
Biotechnology and Biological Sciences Research Council




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.